Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 15.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 144,066 shares of the pharmacy operator’s stock after buying an additional 19,172 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Walgreens Boots Alliance were worth $3,204,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Vontobel Holding Ltd. increased its holdings in shares of Walgreens Boots Alliance by 104.6% in the 1st quarter. Vontobel Holding Ltd. now owns 36,922 shares of the pharmacy operator’s stock valued at $1,752,000 after purchasing an additional 18,879 shares during the period. Moors & Cabot Inc. increased its holdings in shares of Walgreens Boots Alliance by 31.1% in the 1st quarter. Moors & Cabot Inc. now owns 20,791 shares of the pharmacy operator’s stock valued at $931,000 after purchasing an additional 4,931 shares during the period. Sequoia Financial Advisors LLC increased its holdings in shares of Walgreens Boots Alliance by 27.9% in the 1st quarter. Sequoia Financial Advisors LLC now owns 7,569 shares of the pharmacy operator’s stock valued at $339,000 after purchasing an additional 1,651 shares during the period. Candriam Luxembourg S.C.A. increased its holdings in shares of Walgreens Boots Alliance by 0.5% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 63,483 shares of the pharmacy operator’s stock valued at $2,842,000 after purchasing an additional 310 shares during the period. Finally, Baird Financial Group Inc. increased its holdings in shares of Walgreens Boots Alliance by 14.2% in the 1st quarter. Baird Financial Group Inc. now owns 467,533 shares of the pharmacy operator’s stock valued at $20,932,000 after purchasing an additional 58,184 shares during the period. Institutional investors and hedge funds own 57.92% of the company’s stock.

Walgreens Boots Alliance Price Performance

Walgreens Boots Alliance stock opened at $22.63 on Tuesday. The business’s 50-day simple moving average is $23.91 and its 200 day simple moving average is $23.53. The stock has a market cap of $19.52 billion, a price-to-earnings ratio of 34.29, a P/E/G ratio of 1.37 and a beta of 0.74. Walgreens Boots Alliance, Inc. has a 12-month low of $19.68 and a 12-month high of $37.13. The company has a quick ratio of 0.30, a current ratio of 0.66 and a debt-to-equity ratio of 0.27.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its earnings results on Thursday, January 4th. The pharmacy operator reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.62 by $0.04. Walgreens Boots Alliance had a return on equity of 10.48% and a net margin of 0.40%. The firm had revenue of $36.70 billion for the quarter, compared to analysts’ expectations of $34.95 billion. During the same quarter last year, the business earned $1.16 earnings per share. The company’s revenue was up 9.9% compared to the same quarter last year. As a group, research analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.25 earnings per share for the current year.

Walgreens Boots Alliance Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 12th. Investors of record on Tuesday, February 20th will be given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 4.42%. The ex-dividend date is Friday, February 16th. Walgreens Boots Alliance’s dividend payout ratio is presently 290.91%.

Wall Street Analyst Weigh In

A number of research firms recently commented on WBA. TheStreet upgraded Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a report on Monday, January 8th. JPMorgan Chase & Co. upgraded Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and increased their price objective for the stock from $27.00 to $30.00 in a report on Monday, October 23rd. HSBC began coverage on Walgreens Boots Alliance in a report on Friday, December 22nd. They issued a “hold” rating and a $27.00 price objective on the stock. Finally, Barclays assumed coverage on Walgreens Boots Alliance in a report on Wednesday, January 3rd. They issued an “underweight” rating and a $21.00 price objective on the stock. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus price target of $28.25.

Check Out Our Latest Stock Analysis on Walgreens Boots Alliance

Insiders Place Their Bets

In related news, Director Valerie B. Jarrett purchased 4,456 shares of the stock in a transaction on Monday, January 29th. The shares were purchased at an average price of $22.44 per share, with a total value of $99,992.64. Following the transaction, the director now directly owns 4,456 shares of the company’s stock, valued at $99,992.64. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, CEO Timothy C. Wentworth purchased 10,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Friday, January 5th. The stock was acquired at an average cost of $24.22 per share, for a total transaction of $242,200.00. Following the purchase, the chief executive officer now directly owns 585,122 shares of the company’s stock, valued at approximately $14,171,654.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Valerie B. Jarrett bought 4,456 shares of the business’s stock in a transaction dated Monday, January 29th. The shares were bought at an average price of $22.44 per share, with a total value of $99,992.64. Following the completion of the transaction, the director now owns 4,456 shares in the company, valued at approximately $99,992.64. The disclosure for this purchase can be found here. Insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Read More

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.